VRDN insiders were on both sides of the trade this year. Buys came to roughly $30 million (two buyers), sales to $419,000 (one seller).
Biggest single buyer: Fairmount Healthcare Fund II L.P., Director, with roughly $20 million.
Big money check: 214 institutions held VRDN as of Q2 2026, and more funds bought than sold. Looking at the quarterly pattern: Last full quarter: net selling by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Tousignant Jennifer | Executive Officer | Sell | 10,000 | $24.50 | $245K | SEC |
| Aug 20, 2026 | Tousignant Jennifer | Executive Officer | Sell | 4,212 | $24.50 | $103K | SEC |
| May 13, 2026 | Fairmount Healthcare Fund II L.P. | Director | Buy | 1,176,470 | $17.00 | $20.0M | SEC |
| Jan 2, 2026 | Tousignant Jennifer | Executive Officer | Sell | 2,272 | $31.16 | $71K | SEC |
| Oct 27, 2025 | Fairmount Healthcare Fund II GP LLC | Director | Buy | 454,545 | $22.00 | $10.0M | SEC |
| Sep 30, 2024 | Beetham Thomas W. | COO | Buy | 5,000 | $23.41 | $117K | SEC |
| Sep 30, 2024 | Mahoney Stephen F. | CEO | Buy | 21,400 | $23.33 | $499K | SEC |
| Sep 17, 2024 | Fairmount Healthcare Fund II L.P. | Director | Buy | 1,600,000 | $18.75 | $30.0M | SEC |
| Jan 24, 2024 | Fairmount Healthcare Fund II L.P. | Director | Buy | 476,190 | $21.00 | $10.0M | SEC |
| Jun 20, 2023 | Meisner Lara | Executive Officer | Sell | 2,269 | $28.02 | $64K | SEC |
| Jun 20, 2023 | Meisner Lara | Executive Officer | Sell | 27 | $28.35 | $765 | SEC |
| Jun 6, 2023 | Meisner Lara | Executive Officer | Sell | 1,875 | $24.21 | $45K | SEC |
| Jun 6, 2023 | Meisner Lara | Executive Officer | Sell | 5,126 | $25.02 | $128K | SEC |
| Jun 6, 2023 | Meisner Lara | Executive Officer | Sell | 499 | $25.03 | $12K | SEC |
| Apr 12, 2023 | Myers Scott Dunseth | CEO | Buy | 4,000 | $25.37 | $101K | SEC |
In the last 12 months Viridian Therapeutics, Inc.\DE insiders made open-market purchases worth about $30 million and sales worth about $419,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in VRDN was filed on 2026-08-20.
214 investment managers reported holding VRDN in SEC Form 13F filings for Q2 2026.
No congressional trades in VRDN were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).